GLP 1 ONE
LIVE

Serial Number

50074994

Owner

CVS Pharmacy, Inc.

Attorney

Erich G. Rhynhart

Filing Date

Aug 27, 2026

Add to watchlist:

No watchlists yet
View on USPTO

GLP 1 ONE Trademark

Serial Number: 50074994

GLP 1 ONE is a trademark filed by CVS Pharmacy, Inc. on August 27, 2026. The trademark is classified under Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

CVS Pharmacy, Inc. (64 trademarks)

One CVS Drive
Woonsocket, RI 02895

Entity Type: 03

Trademark Details

Filing Date

August 27, 2026

Registration Date

Not Registered

Goods & Services

Retail store and online retail pharmacy services in the field of prescription drugs, healthcare, wellness, general merchandise and medical products; Pharmaceutical cost management and drug utilization review services; Pharmaceutical drug utilization review services, namely, verification of benefits and prior authorization; Facilitating administrative coordination of delivery and access to prescription drugs; Mail order services featuring pharmaceuticals and specialty pharmaceuticals; Specialty pharmaceuticals distributorship services; Procurement services, namely, purchasing pharmaceuticals for others; Retail store services featuring pharmaceutical products; Retail store services featuring generic prescription drugs; Retail pharmacy services

Providing medical information regarding prescription drugs and drug therapy; Providing information regarding patients' prescription drugs and drug therapy; Developing and managing comprehensive programs comprising drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals; Providing consultation in the dispensing of pharmaceuticals and pharmaceutical advice; Providing a website featuring information about nutrition, health, medication, exercise and diet; Providing a website featuring information about nutrition, health, medication, exercise and diet to assist with the management, support, and implementation of dietary and lifestyle changes to meet weight loss goals; providing individualized care management and treatment plans to manage obesity-related comorbid conditions, such as hypertension, dyslipidemia, prediabetes and diabetes; Providing a website featuring medication counseling information; Providing a website featuring information to patients in the field of administering medications; Telepharmacy services, namely, the provision of pharmaceutical consultation and advice

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 27, 2026 MAFR
NEW APPLICATION ENTERED
Aug 27, 2026 NWAP